newsfilter
← Latest News
GlobeNewswire·

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track for one to two DC